Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-22-000527
Filing Date
2022-03-17
Accepted
2022-03-17 17:22:38
Documents
96
Period of Report
2022-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bmmj_10q.htm   iXBRL 10-Q 1347229
2 EX-31.1 bmmj_ex311.htm EX-31.1 11214
3 EX-31.2 bmmj_ex312.htm EX-31.2 11254
4 EX-32.1 bmmj_ex321.htm EX-32.1 4625
  Complete submission text file 0001640334-22-000527.txt   6950704

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bmmj-20220131.xsd EX-101.SCH 83527
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmmj-20220131_lab.xml EX-101.LAB 432666
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmmj-20220131_cal.xml EX-101.CAL 69070
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmmj-20220131_pre.xml EX-101.PRE 382275
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmmj-20220131_def.xml EX-101.DEF 248522
90 EXTRACTED XBRL INSTANCE DOCUMENT bmmj_10q_htm.xml XML 1104682
Mailing Address 750 - 1095 WEST PENDER STREET VANCOUVER A1 V6E 2M6
Business Address 750 - 1095 WEST PENDER STREET VANCOUVER A1 V6E 2M6 604-376-3567
BODY & MIND INC. (Filer) CIK: 0001715611 (see all company filings)

EIN.: 981319227 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-55940 | Film No.: 22749928
SIC: 2834 Pharmaceutical Preparations